Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$744K Sell
2,048
-59
-3% -$20.2K 0.44% 67
2026
Q1
$741K Sell
2,107
-32
-1% -$11.4K 0.51% 57
2025
Q4
$700K Sell
2,139
-3
-0.1% -$952 0.46% 61
2025
Q3
$604K Buy
2,142
+32
+2% +$9.28K 0.41% 71
2025
Q2
$589K Sell
2,110
-40
-2% -$11.3K 0.43% 67
2025
Q1
$670K Buy
2,150
+120
+6% +$35.4K 0.55% 55
2024
Q4
$529K Buy
+2,030
New +$602K 0.42% 70

Other funds holding AMGN

Nautilus Advisors's AMGN Position: Q2 2026 in Review

Nautilus Advisors reduced its Amgen (AMGN) stake by 2.8% in Q2 2026, selling an estimated $20.2K and leaving 2,048 shares worth $744K. The position accounts for 0.44% of the portfolio, ranked #67.

Nautilus Advisors first reported a position in AMGN in Q4 2024 and has held it in 7 quarters since. 1,458 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Nautilus Advisors held 2,048 shares of Amgen worth $744K as of Q2 2026.
  • Nautilus Advisors sold 59 Amgen shares in Q2 2026, an estimated $20.2K.
  • Amgen made up 0.44% of Nautilus Advisors's portfolio in Q2 2026, its #67 holding.
  • Nautilus Advisors first reported a position in Amgen in Q4 2024 and has held it in 7 quarters since.
  • 1,458 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Nautilus Advisors's 13F filing for Q2 2026, filed 14 Jul 2026.